LIC's Q2 Shuffle: Insurance Giant Sells Vedanta, Buys into Yes Bank and Cipla

The Life Insurance Corporation of India (LIC) executed a significant portfolio overhaul in the second quarter, making strategic divestments and fresh investments across various sectors. The insurance major notably reduced its shareholding in Anil Agarwal-led Vedanta while placing fresh bets on companies like Yes Bank and Cipla.Data from the September 2025 quarter reveals that LIC sold a substantial chunk of its Vedanta shares, bringing its stake down to 5.70%. Other companies that saw a reduction in LIC's holdings include Dalmia Bharat, Marico, and BPCL. The insurer's exit from NMDC and Coforge was particularly pronounced, with its stake dropping below 1% in both firms.On the acquisition side, LIC showed strong confidence in the banking and pharma sectors. It aggressively bought shares in Yes Bank, taking its holding to 3.98%, and similarly increased its stake in BSE Ltd to 5.58%. Pharmaceutical firm Cipla saw LIC's stake rise to 6.14%, along with an increased investment in Dr. Reddy's Labs. Technology firms KPIT Technologies and Tata Elxsi were also among the companies where LIC increased its stake, signaling a bullish outlook on the sector.